22nd Century Group Inc. (XXII)
1.04
-0.12 (-10.34%)
At close: Apr 04, 2025, 3:59 PM
1.05
0.95%
After-hours: Apr 04, 2025, 04:35 PM EDT
-10.34% (1D)
Bid | 0.99 |
Market Cap | 2.46M |
Revenue (ttm) | n/a |
Net Income (ttm) | n/a |
EPS (ttm) | -176.23 |
PE Ratio (ttm) | -0.01 |
Forward PE | -0.29 |
Analyst | n/a |
Ask | 1.12 |
Volume | 130,138 |
Avg. Volume (20D) | 920,619 |
Open | 1.12 |
Previous Close | 1.16 |
Day's Range | 0.97 - 1.11 |
52-Week Range | 0.97 - 581.85 |
Beta | 2.03 |
About XXII
22nd Century Group, Inc., an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King names; and SPECTRUM research cigarettes for use in independent clinical studies. The company has collabo...
Industry Tobacco
Sector Consumer Defensive
IPO Date Jan 26, 2011
Employees 56
Stock Exchange NASDAQ
Ticker Symbol XXII
Website https://www.xxiicentury.com
2 months ago
-1.4%
22nd Century Group shares are trading higher after...
Unlock content with
Pro Subscription
2 months ago
+21.57%
22nd Century Group shares are trading higher after the FDA announced it proposed significant step towards reducing nicotine to minimally or nonaddictive level in cigarettes and other combusted tobacco products.